|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online December 17, 2008
doi: 10.1242/10.1242/jcs.035089
Cell Science at a Glance |
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
* Author for correspondence (e-mail: paul.roche{at}nih.gov)
| Introduction |
|---|
|
|
|---|
|
| Movement of newly synthesized MHC class II molecules into antigen-processing compartments |
|---|
|
|
|---|
- and β-chains that are assembled in the endoplasmic reticulum (ER) together with a chaperone protein termed invariant chain (Ii) (Wolf and Ploegh, 1995
β heterodimer and inhibit inappropriate binding of antigen to the MHC class II peptide-binding groove. The newly formed
β-Ii complex exits the ER, traffics through the Golgi complex and the trans-Golgi network (TGN) and is ultimately delivered to lysosome-like antigen-processing compartments. Although there is still some debate as to whether MHC class II traffics to these compartments directly from the TGN, we have proposed (and favor) a pathway that involves an intermediate step at the plasma membrane (PM) (Hiltbold and Roche, 2002
β-Ii complex is efficiently sorted into the endocytic pathway by the recognition of two dileucine-based signals in the cytoplasmic tail of Ii by the clathrin adaptor AP-2, a scaffolding-protein complex that brings together components of the vesicle-formation machinery. The AP-2 complex sorts the
β-Ii complex into clathrin-coated vesicles, which pinch off from the PM and fuse with endocytic compartments (Dugast et al., 2005| Sorting of MHC class II molecules into intraluminal vesicles of multivesicular antigen-processing compartments |
|---|
|
|
|---|
In the case of MHC class II, once in the endocytic pathway,
β-Ii complexes are delivered to lysosome-like multivesicular antigen-processing compartments not for degradation, but for antigenic-peptide binding. Although it is clear that both immature (Ii-associated) and mature (peptide-loaded) MHC class II is found on intraluminal vesicles of these structures (Kleijmeer et al., 2001
; Kleijmeer et al., 1997
; Peters et al., 1995
), the mechanism that regulates the movement of MHC class II to the intraluminal vesicles of MVBs has not been fully resolved. MHC class II is ubiquitylated in immature, but not mature, dendritic cells (DCs) (Shin et al., 2006
; van Niel et al., 2006
), and this modification is added solely to
β complexes that are devoid of Ii (van Niel et al., 2006
). These data suggest that
β-Ii complexes sort onto the intraluminal vesicles of MVBs through an ubiquitin-independent pathway. However, there are conflicting reports regarding the relevance of ubiquitylation to the sorting of MHC-class-II-
β–peptide complexes onto intraluminal vesicles of MVBs (Shin et al., 2006
; van Niel et al., 2006
), and further study will be required to unambiguously delineate the mechanisms that regulate the movement of MHC class II in MVBs.
| A model for the mechanism of antigen loading onto MHC class II molecules |
|---|
|
|
|---|
β-CLIP complex. HLA-DM then stabilizes the empty MHC class II molecule and presumably allows repeated binding and dissociation of peptides to MHC class II until primarily high-affinity antigenic peptides are bound to the peptide-binding groove (Busch et al., 2005| Regulation of antigen loading onto MHC class II molecules |
|---|
|
|
|---|
β-CLIP complexes in both the intracellular antigen-processing compartments and at the PM, and results in diminished immune responses. Recently, primary DCs were shown to also express HLA-DO (Hornell et al., 2006
The lysosomal microenvironment has also been implicated in the regulation of antigen loading. In immature DCs, the elevated pH in lysosome-like organelles results in the inefficient degradation of endocytosed material into antigenic peptides (Trombetta et al., 2003
). Upon DC maturation, the ATP-dependent vacuolar proton pump (V-ATPase) is activated, leading to acidification of these compartments, increased antigen proteolysis and efficient peptide loading onto MHC class II molecules (Trombetta et al., 2003
). The absolute amount of proteinases is lower in professional APCs than in highly destructive cells such as macrophages (Delamarre et al., 2006
; Delamarre et al., 2005
), suggesting that APCs possess mechanisms that `control' proteolysis to limit the destruction of antigenic peptides.
| MHC class II trafficking to the plasma membrane |
|---|
|
|
|---|
Interestingly, MHC class II associates with lipid rafts, membrane microdomains that are rich in cholesterol and sphingolipids, in both the multivesicular antigen-processing compartment as well as at the PM (Poloso et al., 2004
). Disruption of APC lipid-raft integrity leads to antigen-specific defects in T-cell activation that can be overcome by loading the APCs with large amounts of antigen (Anderson et al., 2000
). This suggests that clustering of the MHC-class-II–peptide complexes in membrane microdomains serves to potentiate the activation of T cells. In addition to lipid rafts, a pool of MHC class II is also present in a membrane microdomain termed the tetraspan web (Vogt et al., 2002
). Indeed, lipid rafts, MHC-class-II–peptide complexes and tetraspan-web proteins concentrate at the site of the immunological synapse that exists at the interface between APCs and T cells (Hiltbold et al., 2003
; Vogt et al., 2002
). These findings indicate that the lipid and/or membrane microenvironment in which MHC class II is trafficked plays a key role in determining the antigenicity of a given MHC-class-II–peptide complex.
| Re-entry of MHC-class-II–peptide complexes into the endocytic pathway from the plasma membrane |
|---|
|
|
|---|
| Perspectives |
|---|
|
|
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Anderson, H. A., Hiltbold, E. M. and Roche, P. A. (2000). Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat. Immunol. 1, 156-162.[Medline]
Busch, R., Rinderknecht, C. H., Roh, S., Lee, A. W., Harding, J. J., Burster, T., Hornell, T. M. and Mellins, E. D. (2005). Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression. Immunol. Rev. 207, 242-260.[CrossRef][Medline]
Chow, A., Toomre, D., Garrett, W. and Mellman, I. (2002). Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 418, 988-994.[CrossRef][Medline]
De Gassart, A., Camosseto, V., Thibodeau, J., Ceppi, M., Catalan, N., Pierre, P. and Gatti, E. (2008). MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc. Natl. Acad. Sci. USA 105, 3491-3496.
Delamarre, L., Pack, M., Chang, H., Mellman, I. and Trombetta, E. S. (2005). Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307, 1630-1634.
Delamarre, L., Couture, R., Mellman, I. and Trombetta, E. S. (2006). Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis. J. Exp. Med. 203, 2049-2055.
Denzin, L. K., Sant'Angelo, D. B., Hammond, C., Surman, M. J. and Cresswell, P. (1997). Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 278, 106-109.
Dugast, M., Toussaint, H., Dousset, C. and Benaroch, P. (2005). AP2 clathrin adaptor complex, but not AP1, controls the access of the major histocompatibility complex (MHC) class II to endosomes. J. Biol. Chem. 280, 19656-19664.
Hiltbold, E. M. and Roche, P. A. (2002). Trafficking of MHC class II molecules in the late secretory pathway. Curr. Opin. Immunol. 14, 30-35.[CrossRef][Medline]
Hiltbold, E. M., Poloso, N. J. and Roche, P. A. (2003). MHC class II-peptide complexes and APC lipid rafts accumulate at the immunological synapse. J. Immunol. 170, 1329-1338.
Hornell, T. M., Burster, T., Jahnsen, F. L., Pashine, A., Ochoa, M. T., Harding, J. J., Macaubas, C., Lee, A. W., Modlin, R. L. and Mellins, E. D. (2006). Human dendritic cell expression of HLA-DO is subset specific and regulated by maturation. J. Immunol. 176, 3536-3547.
Hsing, L. C. and Rudensky, A. Y. (2005). The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol. Rev. 207, 229-241.[CrossRef][Medline]
Jensen, P. E. (2007). Recent advances in antigen processing and presentation. Nat. Immunol. 8, 1041-1048.[CrossRef][Medline]
Kleijmeer, M., Ramm, G., Schuurhuis, D., Griffith, J., Rescigno, M., Ricciardi-Castagnoli, P., Rudensky, A. Y., Ossendorp, F., Melief, C. J., Stoorvogel, W. et al. (2001). Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells. J. Cell Biol. 155, 53-63.
Kleijmeer, M. J., Morkowski, S., Griffith, J. M., Rudensky, A. Y. and Geuze, H. J. (1997). Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. J. Cell Biol. 139, 639-649.
Matsuki, Y., Ohmura-Hoshino, M., Goto, E., Aoki, M., Mito-Yoshida, M., Uematsu, M., Hasegawa, T., Koseki, H., Ohara, O., Nakayama, M. et al. (2007). Novel regulation of MHC class II function in B cells. EMBO J. 26, 846-854.[CrossRef][Medline]
Matsuo, H., Chevallier, J., Mayran, N., Le Blanc, I., Ferguson, C., Faure, J., Blanc, N. S., Matile, S., Dubochet, J., Sadoul, R. et al. (2004). Role of LBPA and Alix in multivesicular liposome formation and endosome organization. Science 303, 531-534.
McCormick, P. J., Martina, J. A. and Bonifacino, J. S. (2005). Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments. Proc. Natl. Acad. Sci. USA 102, 7910-7915.
Peters, P. J., Raposo, G., Neefjes, J. J., Oorschot, V., Leijendekker, R. L., Geuze, H. J. and Ploegh, H. L. (1995). Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes. J. Exp. Med. 182, 325-334.
Piper, R. C. and Katzmann, D. J. (2007). Biogenesis and function of multivesicular bodies. Annu. Rev. Cell Dev. Biol. 23, 519-547.[CrossRef][Medline]
Poloso, N. J., Muntasell, A. and Roche, P. A. (2004). MHC class II molecules traffic into lipid rafts during intracellular transport. J. Immunol. 173, 4539-4546.
Sercarz, E. E. and Maverakis, E. (2003). MHC-guided processing: binding of large antigen fragments. Nat. Rev. Immunol. 3, 621-629.[CrossRef][Medline]
Shin, J. S., Ebersold, M., Pypaert, M., Delamarre, L., Hartley, A. and Mellman, I. (2006). Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature 444, 115-118.[CrossRef][Medline]
Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brugger, B. and Simons, M. (2008). Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244-1247.
Trombetta, E. S., Ebersold, M., Garrett, W., Pypaert, M. and Mellman, I. (2003). Activation of lysosomal function during dendritic cell maturation. Science 299, 1400-1403.
van Niel, G., Wubbolts, R., Ten Broeke, T., Buschow, S. I., Ossendorp, F. A., Melief, C. J., Raposo, G., van Balkom, B. W. and Stoorvogel, W. (2006). Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination. Immunity 25, 885-894.[CrossRef][Medline]
Vogt, A. B., Spindeldreher, S. and Kropshofer, H. (2002). Clustering of MHC-peptide complexes prior to their engagement in the immunological synapse: lipid raft and tetraspan microdomains. Immunol. Rev. 189, 136-151.[CrossRef][Medline]
Walseng, E., Bakke, O. and Roche, P. A. (2008). Major histocompatibility complex class II-peptide complexes internalize using a clathrin- and dynamin-independent endocytosis pathway. J. Biol. Chem. 283, 14717-14727.
Wolf, P. R. and Ploegh, H. L. (1995). How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu. Rev. Cell Dev. Biol. 11, 267-306.[CrossRef][Medline]
Zwart, W., Griekspoor, A., Kuijl, C., Marsman, M., van Rheenen, J., Janssen, H., Calafat, J., van Ham, M., Janssen, L., van Lith, M. et al. (2005). Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape. Immunity 22, 221-233.[CrossRef][Medline]
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
M. Jabbour, E. M. Campbell, H. Fares, and L. Lybarger Discrete Domains of MARCH1 Mediate Its Localization, Functional Interactions, and Posttranscriptional Control of Expression J. Immunol., November 15, 2009; 183(10): 6500 - 6512. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||